Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 15 years by 2.64% on an annualized basis producing an average annual return of 15.99%. Currently, Cytokinetics has a market capitalization of $9.70 billion.

Buying $1000 In CYTK: If an investor had bought $1000 of CYTK stock 15 years ago, it would be worth $10,260.61 today based on a price of $69.74 for CYTK at the time of writing.

Cytokinetics’s Performance Over Last 15 Years

comp_fig

Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.